Drawing on his decades-long experience at the intersection of politics and economics, he now unpacks what the new phase of ...

While many often say the pharmaceutical industry has the most powerful lobby, the truth is many politicians have grown ...

GenAI is changing pharma operations. Explore real-world tools and use cases for AI in pharmaceutical industry workflows.

The country’s manufacturing output posted growth in April, driven mainly by the uptick in production of basic metals, ...

Federal Circuit reshapes foundational requirements for viability of a case in the ITC - Pharmaceutical and life sciences companies have ...

US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

The decree signed by Donald Trump to drastically reduce drug prices in the United States could, indirectly, benefit ...

Xiangxiang Ma, a partner of Anjie Broad Law Firm, explores the various ways in which a recent U.S. executive order on drug pricing is impacting Chinese pharmaceutical companies’ license-out model ...

Industrial production in the eurozone's two largest economies declined in the first month of President Trump's global tariff blitz, a sign that an economic slowdown is underway after a start to the ...

Jon Bardsley of Thermo Fisher offers his perspective regarding the advancement of PFAS detection in pharmaceutical manufacturing with liquid chromatography-mass spectrometry (LC-MS), and the influence ...

America's pharmaceutical sector is facing huge uncertainty from the tariff threat, cuts at the US Department of Health, and a ...

IndustryWeek editors look into that story, plus an electric boat makes history, what's up with product recalls, Morgan Li ...